biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > 24-hour CEO

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Dec 15, 2020 6:52am

192 Views

Post# 32106917

RE:RE:RE:RE:RE:RE:24-hour CEO

,,,Im showing 68 Million shares outstanding with a 66+ Million float..not including warrants and options...about 5 years ago we were ruffly half that number I believe.

We are told the next few months will have interesting data released and possibly a deal or two.

I would however like to see DrDR back home in Connecticut,,our head office where the North American Biotech center is said to exist. Come home DrDR!

,,,,,,,,,,,,,,,,,,,,,,,,,:o)

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario